Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
PRProfound Medical Corp. logo

Profound Medical Corp. (PROF)

NASDAQ Capital Market · Currency in USD
$5.56 ▼ -0.20 (-3.47%)
At close: Oct 23, 4:00 PM ET. Market closed.
$5.56 ▲ +0.00 (+0.00%)
After hours: Oct 23, 7:52 PM ET

Summary

Previous Close
$5.76
Open
$5.79
Day's Range
$5.54 – $5.79
52 Week Range
$4.80 – $8.95
Volume
135,858
Avg. Volume
160,282
Market Cap
$203.12M
Beta (5Y Monthly)
0.53
PE Ratio (TTM)
--
EPS (TTM)
-$0.89
Earnings Date
Nov 5, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$11.00

Profile: Profound Medical Corp.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
162
CEO
Arun Swarup Menawat

Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company markets its solutions across Canada, Germany, the United States, and Finland.

Earnings

Next report: Thu, Nov 5, 2026
EPS estimate -$0.19 · Revenue est. $8.82M
DateEst.Actual
Aug 6, 2026-$0.22-$0.26Miss
May 7, 2026-$0.24-$0.19Beat
Mar 5, 2026-$0.27-$0.27Beat
Nov 13, 2025-$0.38-$0.26Beat
Aug 14, 2025-$0.43-$0.52Miss
May 8, 2025-$0.29-$0.36Miss

Analyst view

Consensus price target
$11.00 ▲ +97.8%
Range $11.00 – $11.00
Rating: Buy
Buy 86% · Hold 14% · Sell 0%

Get free alerts on PROF and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.